DRUG COMBINATION COMPRISING AN ANGIOTENSIN II RECEPTOR ANTAGONIST, A NEUTRAL ENDOPEPTIDASE INHIBITOR AND A MINERALCORTICOID RECEPTOR ANTAGONIST

摘要

A specific combination of a an ARB, such as valsartan, a NEP inhibitor or prodrug thereof, such as sacubitril, and an MR antagonist, such as finerenone; and related invention embodiments.